Structure | Chemical Name | CAS | MF |
|
bacterioferritin comigratory protein
|
136253-16-2
|
|
|
noradrenaline transporter
|
136253-20-8
|
|
|
M-twist protein
|
136253-27-5
|
|
|
strand exchange protein 1
|
136253-28-6
|
|
|
MFT1 protein
|
136253-29-7
|
|
|
prolactin-like protein IV
|
136253-31-1
|
|
|
FixJ protein
|
136253-38-8
|
|
|
2H-Pyrrolo[2,3-b]pyridin-2-one, 1,3-dihydro-1-(phenylMethyl)-
|
136257-31-3
|
C14H12N2O
|
|
H-Lys(4-nitro-Z)-pyrrolidide . HCl
|
136259-18-2
|
C18H26N4O5
|
|
(3N-[(2S,3S)-2-AMINO-3-METHYL-PENTANOYL]-1,3-THIAZOLIDINE) HEMIFUMARATE
|
136259-20-6
|
C9H18N2OS
|
|
Benzeneacetonitrile, 2-formyl-6-methyl- (9CI)
|
136262-98-1
|
C10H9NO
|
|
Benzeneacetonitrile, 2-formyl-3-methyl- (9CI)
|
136262-99-2
|
C10H9NO
|
|
Benzeneacetonitrile, 2-formyl-4-methyl- (9CI)
|
136263-00-8
|
C10H9NO
|
|
5,8-Epoxyimidazo[1,5-a]pyridine(9CI)
|
136263-26-8
|
C7H4N2O
|
|
1,3-Dioxolane-4-ethanol,2-(1-methylethyl)-,cis-(9CI)
|
136264-03-4
|
C8H16O3
|
|
1,3-Dioxolane-4-ethanol,2-(1-methylethyl)-,trans-(9CI)
|
136264-04-5
|
C8H16O3
|
|
1,3-Dioxane-4-methanol,2-(1-methylethyl)-,trans-(9CI)
|
136264-10-3
|
C8H16O3
|
|
Z-2-Bromo-4,4,4-trifluorbutenoic acid, ethyl ester
|
136264-28-3
|
C6H6BrF3O2
|
|
1,3-DibroMo-5-ethoxybenzene
|
136265-19-5
|
C8H8Br2O
|
|
2-AMino-6H-[1,3,4]thiadiazine-5-carboxylic acid
|
136265-68-4
|
C4H5N3O2S
|
|
BenzaMide, 4-[[(2,4-diaMino-6-pteridinyl)Methyl]aMino]-
|
136265-94-6
|
C14H14N8O
|
|
cinatrin A
|
136266-33-6
|
C18H26O8
|
|
cinatrin B
|
136266-34-7
|
C18H28O8
|
|
cinatrin C1
|
136266-35-8
|
C18H30O8
|
|
cinatrin C2
|
136266-36-9
|
C18H30O8
|
|
cinatrin C3
|
136266-37-0
|
C18H30O8
|
|
4H-1,3-Oxazine,4-ethenyl-6-fluoro-5,6-dihydro-2,6-dimethyl-,trans-(9CI)
|
136271-65-3
|
C8H12FNO
|
|
BOC-L-BETA-HOMOARGININE(TOS)
|
136271-81-3
|
C19H30N4O6S
|
|
Ethanone, 1-[5-(1-hydroxyethylidene)-1,3-cyclopentadien-1-yl]-, (Z)- (9CI)
|
136272-06-5
|
C9H10O2
|
|
2,6-Difluoro-4-chloronitrobenzene
|
136272-31-6
|
C6H2ClF2NO2
|
|
(R,R'')-2,2''-Bis(diphenylphosphino)-1,1''-biferrocene
|
136274-57-2
|
C34H26P2.2C5H5.2Fe
|
|
2-(3-(bromomethyl)phenyl)propan-2-ol
|
136279-23-7
|
C10H13BrO
|
|
1H-Indole-3-aceticacid,5-propyl-(9CI)
|
136281-78-2
|
C13H15NO2
|
|
1H-Pyrazole-5-carbonyl chloride, 3-cyclopropyl-1-methyl- (9CI)
|
136283-92-6
|
C8H9ClN2O
|
|
2-butyl-3-[[4-[2-(2H-tetrazol-5-yl)phenyl]phenyl]methyl]benzoimidazole -4-carboxylic acid
|
136284-47-4
|
C26H24N6O2
|
|
Ethyl 2-((tert-butoxycarbonyl)amino)-3-nitrobenzoate
|
136285-65-9
|
C14H18N2O6
|
|
2-[[(2'-Cyano[1,1'-biphenyl]-4-yl)methyl]amino]-3-nitro-benzoic acid ethyl ester
|
136285-67-1
|
C23H19N3O4
|
|
Azilsartan
|
136285-68-2
|
C28H27N3O6
|
|
Ethyl-3-Amino-2-[(2'-Cyanoiphenyl-4-yl) Methyl]-Amino Benzoate
|
136285-69-3
|
C23H21N3O2
|
|
WS 009A
|
136286-49-2
|
C24H25NO10S
|
|
WS 009B
|
136286-50-5
|
C24H25NO11S
|
|
3-Hexen-5-yn-2-one, 6-(dimethylamino)- (9CI)
|
136287-56-4
|
C8H11NO
|
|
Ethanethioic acid, S-(1-acetyl-4-pyrazolidinyl) ester
|
136290-22-7
|
C7H12N2O2S
|
|
ANTHRANILIC ACID, N-BOC-4-CHLORO
|
136290-47-6
|
C12H14ClNO4
|
|
3-(METHYLAMINO)AZETIDINE DIHYDROCHLORIDE
|
136293-86-2
|
C4H12Cl2N2
|
|
4(4'-trifluoroMethylphenyl)butanoic acid
|
136295-01-7
|
C11H11F3O2
|
|
Benzenebutanoyl chloride, 4-(trifluoroMethyl)-
|
136295-02-8
|
C11H10ClF3O
|
|
4-(3-OXO-PROPYL)-BENZONITRILE
|
136295-53-9
|
C10H9NO
|
|
3,5-DIMETHYL-4-(TRIBUTYLSTANNYL)ISOXAZOLE
|
136295-80-2
|
C17H33NOSn
|
|
3,5-DiMethyl-4-(2-nitrophenyl)isoxazole
|
136295-82-4
|
C11H10N2O3
|
|
N-methyltacrine
|
136297-33-1
|
C14H16N2
|
|
Azilsartan pharMaceutical interMediate
|
136304-78-4
|
C22H19N3O2
|
|
5-(methoxymethylene)-2,4-imidazolidinedione
|
136308-39-9
|
C5H6N2O3
|
|
2-chloro-6-ethoxypyrazine
|
136309-02-9
|
C6H7ClN2O
|
|
2-Chloro-6-propyloxypyrazine
|
136309-03-0
|
C7H9ClN2O
|
|
2-CYANO-6-METHYLPYRAZINE
|
136309-04-1
|
C6H5N3
|
|
2-Ethoxy-6-methoxypyrazine
|
136309-05-2
|
|
|
N-(6-Methoxy-2-pyrazinyl)acetamide
|
136309-06-3
|
C7H9N3O2
|
|
6-METHOXY-PYRAZINE-2-CARBONITRILE
|
136309-07-4
|
C6H5N3O
|
|
6-Methoxy-2-pyrazinecarboxylic acid ethyl ester
|
136309-08-5
|
C8H10N2O3
|
|
6-Methoxy-N,N-dimethyl-2-pyrazinamine
|
136309-09-6
|
C7H11N3O
|
|
6-(Dimethylamino)-2-pyrazinecarboxylic acid ethyl ester
|
136309-10-9
|
|
|
2-Chloro-5-ethoxypyrazine
|
136309-11-0
|
C6H7ClN2O
|
|
N-(5-Chloro-2-pyrazinyl)acetamide
|
136309-12-1
|
C6H6ClN3O
|
|
5-Chloro-N,N-dimethyl-2-pyrazinamine
|
136309-13-2
|
C6H8ClN3
|
|
5-Methoxy-N,N-dimethyl-2-pyrazinamine
|
136309-14-3
|
C7H11N3O
|
|
Scopine-2,2-dithienyl glycolate
|
136310-64-0
|
C18H19NO4S2
|
|
rel-(1R,3S,5S)-8-Methyl-8-azabicyclo[3,2,1]oct-6-en-yl-2-hydroxy-2,2-dithiophen-2-yl acetate
|
136310-66-2
|
C18H19NO3S2
|
|
Tiotropium bromide
|
136310-93-5
|
C19H22BrNO4S2
|
|
Tiotropium EP Impurity C
|
136310-95-7
|
C19H22BrNO3S2
|
|
1-METHYLPIPERIDINE-2-CARBOXYLIC ACID HYDROCHLORIDE
|
136312-85-1
|
C7H14ClNO2
|
|
(3S,4E)-Methyl 3-(dimethylphenylsilyl)-4-hexenoate
|
136314-66-4
|
C15H22O2Si
|
|
Cyclo(glycyl-L-prolyl-L-phenylalanyl-L-prolylglycyl-L-prolyl-L-phenyla lanyl-L-prolyl)
|
136314-94-8
|
C42H52N8O8
|
|
6-hydroxyl-1,6-dihydropurine ribonucleoside
|
136315-04-3
|
C10H14N4O5
|
|
versicolactone A
|
136315-17-8
|
C15H20O2
|
|
cis-2-(tert-Butoxycarbonylamino)-1-cyclopentanecarboxylic acid
|
136315-70-3
|
C11H19NO4
|
|
Boc-trans-2-aMinocyclopentane
carboxylic acid
|
136315-71-4
|
C11H19NO4
|
|
(1R,2R)-(-)-2-Amino-1-cyclopentanecarboxylic acid
|
136315-77-0
|
C6H11NO2
|
|
FULLERENE C78
|
136316-32-0
|
C78
|
|
(2-butyl-1H-imidazole-4,5-diyl)dimethanol
|
136317-69-6
|
C9H16N2O2
|
|
6-BROMOPENTACYCLO[6.3.0.0(2,6).0(3,10).0(5,9)]UNDECAN-4-ONE
|
136319-47-6
|
C11H11BrO
|
|
3-hydroxy-15-keto-chol-8(14)-en-24-oic acid
|
136320-56-4
|
C24H36O4
|
|
3-hydroxy-24-dimethylaminochol-8(14)-en-15-one
|
136320-61-1
|
C26H43NO2
|
|
METHYL-13C SULFOXIDE
|
136321-15-8
|
C2H6OS
|
|
4-(4-PENTYLCYCLOHEXYL)PHENYLBORONIC ACID
|
136321-96-5
|
C17H27BO2
|
|
Benzoic acid, 3-nitro-, phenylMethyl ester
|
136322-11-7
|
C14H11NO4
|
|
4-ETHOXY-2-PHENYL-5-PYRIMIDINECARBOXYLIC ACID
|
136326-10-8
|
C13H12N2O3
|
|
2-Aziridinecarboxamide,1-butyl-2-methyl-(9CI)
|
136328-22-8
|
C8H16N2O
|
|
Cyclopropanecarboxylic acid, 1-amino-2-propyl-, (1S,2S)- (9CI)
|
136328-39-7
|
C7H13NO2
|
|
Tert-Butyl N-[2-Oxo-1-Phenyl-2-(Pyrrolidin-1-Yl)Ethyl]Carbamate
|
136329-30-1
|
C17H24N2O3
|
|
(R)-(-)-N-METHYL-1-PHENYL-2-(1-PYRROLIDINO)ETHYLAMINE
|
136329-39-0
|
C13H20N2
|
|
4,7-Etheno-1,3-dioxolo[4,5-c]pyridine(9CI)
|
136330-36-4
|
C8H5NO2
|
|
(1-6)-mannopyranan sulfate
|
136331-89-0
|
|
|
ORFI peptide
|
136331-92-5
|
|
|
3-(4-chlorophenyl)cyclohexanone
|
136333-71-6
|
C12H13ClO
|
|
methyl 4-(2-bromoethyl)benzoate
|
136333-97-6
|
C10H11BrO2
|
|
2,5-DIETHOXY-4-MORPHOLINOANILINE DIHYDROCHLORIDE
|
136334-84-4
|
C14H24Cl2N2O3
|
|
6-O-heptopyranosylglucopyranose
|
136337-35-4
|
C13H24O12
|
|
3-(2,6-DIISOPROPYL-4-PHENOXYPHENYL)-1-TERT-BUTYLUREA
|
136337-67-2
|
C23H32N2O2
|
|
2-amino-4-hydroxy-6-(3-hydroxy-4-phosphonoxy-1-butenyl)pteridine
|
136338-57-3
|
C10H12N5O6P
|